famotidine has been researched along with Mouth Diseases in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Mouth Diseases: Diseases involving the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Orolingual angioedema is a rare adverse effect of tissue plasminogen activator (tPA), with an incidence of 1% to 5%." | 1.43 | A Novel Approach to the Treatment of Orolingual Angioedema After Tissue Plasminogen Activator Administration. ( Droege, C; Kneale, H; Pahs, L; Pancioli, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stokes, NA | 1 |
| Lemos, JP | 1 |
| Pahs, L | 1 |
| Droege, C | 1 |
| Kneale, H | 1 |
| Pancioli, A | 1 |
2 other studies available for famotidine and Mouth Diseases
| Article | Year |
|---|---|
Male patient with throat swelling and painful swallowing.
Topics: Adenoids; Adult; Angioedema; Anti-Inflammatory Agents; Deglutition Disorders; Dexamethasone; Diphenh | 2013 |
A Novel Approach to the Treatment of Orolingual Angioedema After Tissue Plasminogen Activator Administration.
Topics: Aged; Angioedema; Anti-Inflammatory Agents; Diphenhydramine; Drug Therapy, Combination; Famotidine; | 2016 |